|Articles|September 7, 2021

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Brad Hertz is a BRCA2 previvor who enrolled himself in a clinical trial for prostate cancer.

Clinical trials and research studies are how we move science and research forward. During Prostate Cancer Awareness Month we honor all those with, or at risk for, prostate cancer and we share this story of Brad Hertz, BRCA2 previvor who enrolled himself in a prostate cancer clinical trial at the National Institutes of Health.

https://facingourrisk.org/blog/a-different-kind-of-trial-a-litigation-attorneys-take-on-being-in-a-national-institutes-of-health-clinical-trial/?utm_source=CURE&utm_medium=website

Stay up to date on cancer updates, research and education

A Different Kind of Trial for This Attorney – Brad Hertz Enrolls in a Prostate Cancer Clinical Trial

Trending on CURE

The First-Ever Personalized Cancer Vaccine to Pass a Phase 3 Trial Just Beat Keytruda Alone

"Lung Cancer Made Me Who I Am Today” : Juanita Segura on Her Journey and Finding Hope

She Was the One Everyone Counted On: When a Mother and Wife Gets Cancer

When Cancer Diagnoses Lead to Guilt

Keytruda Plus Xgeva Shrank Tumors in 31% of Patients With Clear Cell Kidney Cancer